The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions.
Saved in:
| Title: | The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions. |
|---|---|
| Authors: | Odintsov I; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Lui AJW; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Sisso WJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Gladstone E; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Liu Z; Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China., Delasos L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Kurth RI; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Sisso EM; Development Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Vojnic M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Khodos I; Anti-tumor Core Facility, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Mattar MS; Anti-tumor Core Facility, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., de Stanchina E; Anti-tumor Core Facility, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Leland SM; Elevation Oncology, Inc. New York, New York., Ladanyi M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. ladanyim@mskcc.org somwarr@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Somwar R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. ladanyim@mskcc.org somwarr@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jun 01; Vol. 27 (11), pp. 3154-3166. Date of Electronic Publication: 2021 Apr 06. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
